USA029 University of Miami Sylvester Comprehensive Cancer Center 1550 NW 10th Avenue 33173 Miami FL Ikpeazu Chukwuemeka N

Clinical research site in Miami, Florida

As of July 2026, 1 paid clinical trial is recruiting at USA029 University of Miami Sylvester Comprehensive Cancer Center 1550 NW 10th Avenue 33173 Miami FL Ikpeazu Chukwuemeka N in Miami, Florida. Active studies at this site focus on Limited-stage Small Cell Lung Cancer (LS-SCLC) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at USA029 University of Miami Sylvester Comprehensive Cancer Center 1550 NW 10th Avenue 33173 Miami FL Ikpeazu Chukwuemeka N (1)

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

for Limited-stage Small Cell Lung Cancer (LS-SCLC)

29 locations incl. Goodyear

Sponsor: Shanghai Junshi Bioscience Co., Ltd.

Sex: All·Age: 18+

Code: NCT06095583·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

More research sites in Miami

University of Miami (258 trials)
University of Miami Miller School of Medicine-Sylvester Cancer Center (76 trials)
Nicklaus Children's Hospital (57 trials)
Miami Cancer Institute (43 trials)
UM Sylvester Comprehensive Cancer Center at Kendall (32 trials)
Sylvester Comprehensive Cancer Center (28 trials)
GSK Investigational Site (19 trials)
University of Miami Miller School of Medicine (19 trials)
Miami Cancer Institute at Baptist Health, Inc. (17 trials)
Bascom Palmer Eye Institute (16 trials)

Explore more

Paid clinical trials in Miami, FL · Florida clinical trials